Related Experiment Video
Updated: Oct 4, 2026

Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing
Published on: February 13, 2016
Interactions between pharmaceutically active compounds and organic foulants in ultrafiltration processes
Bongyeon Jung1, Seungyeon Han2, Choe Earn Choong3
1Department of Environmental Science & Engineering, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Republic of Korea.
Abstract:
In this study, we systematically investigated the fundamental interactions between pharmaceutically active compounds (PhACs) and organic fouling layers during ultrafiltration (UF) processes. Two representative PhACs, propranolol (PRP) and naproxen (NPX), were filtered through polyethersulfone membranes fouled with natural organic matter surrogates, including humic acid, bovine serum albumin, and sodium alginate. The results suggested that electrostatic interactions contributed substantially to the association of ionic PhACs with organic fouling layers under the investigated UF conditions. Electrostatic attraction likely promoted the association of cationic PRP with negatively charged fouling layers, whereas electrostatic repulsion likely limited the association of anionic NPX with these layers under neutral and alkaline conditions. Experiments conducted at high ionic strength (1 M NaCl) further supported these mechanisms by suppressing electrostatic interactions, resulting in decreased PRP and improved NPX association with fouling layers. When electrostatic contributions were reduced, the observed PhAC retention was consistent with hydrophobic interaction, with possible additional contributions from π-π interactions and hydrogen bonding. These findings highlight the influence of foulant chemistry on pharmaceutical association.
Related Concept Videos
Drug Elimination by Renal Route: Tubular Secretion
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Drug Biotransformation: Overview
Filtration
Drug Elimination by Renal Route: Tubular Reabsorption

